ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.00%
US Dollar vs MXN
16.75933
-0.21%
Brent Oil
84.14
0.23%
Bitcoin
63,216.79
0.27%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
10/05/202407:10PR Newswire (US)1954 - 2024 Relais & Châteaux celebrates its 70th anniversary
10/05/202407:10PR Newswire (US)International Tower Hill Mines Files 2024 First Quarter Financial ResultsTSX:ITHInternational Tower Hill Mines Ltd New
10/05/202407:10PR Newswire (US)atNorth Shortlisted for Datacloud Global Awards, The Energy Awards and The Women in Green Business Awards
10/05/202407:09Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BPOPOPopular Inc (PK)
10/05/202407:09PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - MAPTSXV:MAPMaple Peak Investments Inc
10/05/202407:07PR Newswire (US)Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
10/05/202407:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NOGWQNogin Inc (PK)
10/05/202407:05GlobeNewswire Inc.Freshly Baked NYC Delivery Service Introduces Its First Recreational Dispensary to the Bronx Community
10/05/202407:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
10/05/202407:05Business WireWolters Kluwer survey cites maintaining compliance as a top concern among impacted U.S. Corporate Transparency Act reporting companies
10/05/202407:05Business WireAlTi Global, Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ALTIAITi Global Inc
10/05/202407:05Business WireBoston Omaha Announces Departure of Co-CEO Alex Rozek as Adam Peterson Continues in Chair and CEO RolesNYSE:BOCBoston Omaha Corporation
10/05/202407:05PR Newswire (US)G.L.A.M. Body Scrubs Wins $100,000 Comerica Hatch Detroit Contest by TechTownNYSE:CMAComerica Inc
10/05/202407:04Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:VCXB10X Capital Venture Acquisition Corp III
10/05/202407:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:COLLCollegium Pharmaceutical Inc
10/05/202407:02IH Market NewsNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More NewsNASDAQ:GOOGLAlphabet Inc
10/05/202407:02GlobeNewswire Inc.Telos Corporation Announces First Quarter Results Above Guidance: Reports $29.6 Million of Revenue, 37.0% GAAP Gross Margin, and 42.2% Cash Gross MarginNASDAQ:TLSTelos Corporation
10/05/202407:01Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:VRTXVertex Pharmaceuticals Inc
10/05/202407:01PR Newswire (US)Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug CandidateNASDAQ:INTSIntesity Therapeutics Inc
10/05/202407:01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
10/05/202407:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:CHTChunghwa Telecom Co Ltd
10/05/202407:00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FRMEPFirst Merchants Corporation
10/05/202407:00InvestorsHub NewsWireAvant Technologies Equipping AI-Managed Data Center with High Performance Computing SystemsUSOTC:AVAIAvant Technologies Inc (QB)
10/05/202407:00Business WireSunOpta Inc. to Participate in Upcoming Investor ConferencesNASDAQ:STKLSunOpta Inc
10/05/202407:00Business WireNotice of Greylock McKinnon Associates, Inc. Data Breach
10/05/202407:00GlobeNewswire Inc.UPCX to Host AMA with CMO Mr. Sato on Wallet Testnet and Milestones
10/05/202407:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
10/05/202407:00Business WireSugarCRM Named 2024 CRM Excellence Award Winner for the Fourth Year Running
10/05/202407:00Business WireWisdomTree Reports Monthly Metrics for April 2024NYSE:WTWisdomTree Inc
10/05/202407:00Business WireViking Announces New Vice President of Investor RelationsNYSE:VIKViking Holdings Ltd

Su Consulta Reciente

NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
FX
USDMXN
US Dollar vs MXN
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
AMEX
XLF
Financial Select Sector
CCOM
SILVER
SILVER
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados